Multiomics approach identifies SERPINB1 as candidate progression biomarker for Spinocerebellar Ataxia type 2
Luis Enrique Almaguer-Mederos, Jana Key, NE Sen…·Georg W. J. Auburger
The paper identifies SERPINB1 as a potential biomarker for SCA2 progression through multi-omics analysis in mice and validation in human patients.